Dualitas Therapeutics · Funding, investors and similar startups

About

The company develops bispecific antibody therapies for patients with autoimmune and allergic diseases using a cell-surface proximity screening engine.

Source

Funding history · 0

No rounds recorded yet. The agent looks for them over time.

Similar companies

Dualitas
This biotechnology company develops bispecific antibody therapies for patients with immune and inflammatory diseases using a proprietary functional discovery platform.
Dualyx
This company develops immune-modulating therapies targeting regulatory T cells to treat patients with autoimmune diseases.
Attovia Therapeutics
The company develops biparatopic biologics to treat patients with immune-mediated diseases and cancer through a modular protein design platform.
Ability Biologics
The company develops antibody biotherapeutics using artificial intelligence for patients with cancer, autoimmune and inflammatory diseases.
ATB Therapeutics
The company develops engineered antibody therapies for patients with cancer and autoimmune diseases using a proprietary bioengineering platform.
Bambusa Therapeutics
The company develops bispecific antibodies for patients with immunological and inflammatory disorders.
Immune Regulation
The company develops biotherapeutic treatments to reset the immune system for patients with autoimmune and allergic diseases.
T-Therapeutics
The company develops T cell receptor therapeutics and bispecific engagers for patients with cancer and autoimmune diseases.